The National Institutes of Health (NIH) is offering this grant to support the advancement of diagnostic technologies for tuberculosis (TB) drug susceptibility testing (DST). This initiative aims to address the critical need for improved methods to identify effective treatments for TB. Specifically, this grant is for the purpose of fostering the development of innovative diagnostic solutions, including point-of-care (POC) DST tools that can provide rapid results directly where patients are treated. Furthermore, the funding will support the creation of companion diagnostics, which are essential for guiding the appropriate use of new TB drugs. The ultimate goal is to enhance the accuracy and accessibility of TB testing, leading to more effective treatment strategies and better patient outcomes globally.
Opportunity ID: 338469
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-AI-22-016 |
Funding Opportunity Title: | Improved Drug Susceptibility Testing (DST) for Tuberculosis (R01 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Mar 02, 2022 |
Last Updated Date: | Mar 02, 2022 |
Original Closing Date for Applications: | Jul 08, 2022 |
Current Closing Date for Applications: | Jul 08, 2022 |
Archive Date: | Aug 13, 2022 |
Estimated Total Program Funding: | – |
Award Ceiling: | $500,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Special district governments For profit organizations other than small businesses City or township governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) State governments Independent school districts Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to support the development of new diagnostic technologies for tuberculosis (TB) drug susceptibility testing (DST), including point of care (POC) DST and companion diagnostics for new TB drugs. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-22-016.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 338469 Full Announcement-RFA-AI-22-016 -> RFA-AI-22-016-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-G | Use for due dates on or after January 25, 2022 | PKG00272378 | Jun 08, 2022 | Jul 08, 2022 | View |
Package 1
Mandatory forms
338469 RR_SF424_5_0-5.0.pdf
338469 PHS398_CoverPageSupplement_5_0-5.0.pdf
338469 RR_OtherProjectInfo_1_4-1.4.pdf
338469 PerformanceSite_4_0-4.0.pdf
338469 RR_KeyPersonExpanded_4_0-4.0.pdf
338469 PHS398_ResearchPlan_4_0-4.0.pdf
338469 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
338469 RR_Budget_3_0-3.0.pdf
338469 RR_SubawardBudget30_3_0-3.0.pdf
338469 PHS398_ModularBudget_1_2-1.2.pdf
338469 PHS_AssignmentRequestForm_3_0-3.0.pdf